- Home
- AXGN vs XNCR Comparison
AXGN vs XNCR Comparison
Compare AXGN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- XNCR
- Stock Information
- Founded
- AXGN N/A
- XNCR 1997
- Country
- AXGN United States
- XNCR United States
- Employees
- AXGN N/A
- XNCR N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- AXGN Health Care
- XNCR Health Care
- Exchange
- AXGN Nasdaq
- XNCR Nasdaq
- Market Cap
- AXGN 577.0M
- XNCR 547.8M
- IPO Year
- AXGN N/A
- XNCR 2013
- Fundamental
- Price
- AXGN $16.26
- XNCR $8.41
- Analyst Decision
- AXGN Strong Buy
- XNCR Buy
- Analyst Count
- AXGN 5
- XNCR 9
- Target Price
- AXGN $26.00
- XNCR $25.00
- AVG Volume (30 Days)
- AXGN 1.9M
- XNCR 718.6K
- Earning Date
- AXGN 08-05-2025
- XNCR 08-06-2025
- Dividend Yield
- AXGN N/A
- XNCR N/A
- EPS Growth
- AXGN N/A
- XNCR N/A
- EPS
- AXGN N/A
- XNCR N/A
- Revenue
- AXGN $203,271,000.00
- XNCR $146,929,000.00
- Revenue This Year
- AXGN $17.86
- XNCR N/A
- Revenue Next Year
- AXGN $16.27
- XNCR $28.84
- P/E Ratio
- AXGN N/A
- XNCR N/A
- Revenue Growth
- AXGN 17.17
- XNCR N/A
- 52 Week Low
- AXGN $9.22
- XNCR $6.92
- 52 Week High
- AXGN $21.00
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- AXGN 79.03
- XNCR 55.89
- Support Level
- AXGN $15.10
- XNCR $7.13
- Resistance Level
- AXGN $15.79
- XNCR $7.99
- Average True Range (ATR)
- AXGN 0.79
- XNCR 0.53
- MACD
- AXGN 0.14
- XNCR 0.06
- Stochastic Oscillator
- AXGN 94.86
- XNCR 94.90
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.